These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34149259)

  • 1. Use of Flash Continuous Glucose Monitoring Is Associated With A1C Reduction in People With Type 2 Diabetes Treated With Basal Insulin or Noninsulin Therapy.
    Wright EE; Kerr MSD; Reyes IJ; Nabutovsky Y; Miller E
    Diabetes Spectr; 2021 May; 34(2):184-189. PubMed ID: 34149259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flash CGM associated with event reduction in nonintensive diabetes therapy.
    Miller E; Kerr MSD; Roberts GJ; Nabutovsky Y; Wright E
    Am J Manag Care; 2021 Nov; 27(11):e372-e377. PubMed ID: 34784145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Adherence, A1C Improvement, and Type of Continuous Glucose Monitoring System in People with Type 1 Diabetes or Type 2 Diabetes Treated with Intensive Insulin Therapy.
    Nemlekar PM; Hannah KL; Green CR; Norman GJ
    Diabetes Ther; 2024 Mar; 15(3):639-648. PubMed ID: 38289464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Change in A1C and Use of Professional Continuous Glucose Monitoring in Adults With Type 2 Diabetes on Noninsulin Therapies: A Real-World Evidence Study.
    Nemlekar PM; Hannah KL; Norman GJ
    Clin Diabetes; 2023; 41(3):359-366. PubMed ID: 37456087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coverage for Continuous Glucose Monitoring for Individuals with Type 2 Diabetes Treated with Nonintensive Therapies: An Evidence-Based Approach to Policymaking.
    Aleppo G; Hirsch IB; Parkin CG; McGill J; Galindo R; Kruger DF; Levy CJ; Forlenza GP; Umpierrez GE; Grunberger G; Bergenstal RM
    Diabetes Technol Ther; 2023 Oct; 25(10):741-751. PubMed ID: 37471068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Changes in A1C Following Continuous Glucose Monitoring Acquisition in People with Sub-Optimally Treated Type 2 Diabetes Taking GLP-1 RA Therapy.
    Miller E; Chuang JS; Roberts GJ; Nabutovsky Y; Virdi N; Wright EE
    Diabetes Ther; 2024 Jul; ():. PubMed ID: 39008235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced Rate of Hospitalizations for Acute Diabetes Events Before and After FreeStyle Libre
    Riveline JP; Levrat-Guillen F; Detournay B; Vicaut E; De Pouvourville G; Emery C; Guerci B
    Diabetes Technol Ther; 2024 Jul; ():. PubMed ID: 38885325
    [No Abstract]   [Full Text] [Related]  

  • 9. Flash CGM Is Associated With Reduced Diabetes Events and Hospitalizations in Insulin-Treated Type 2 Diabetes.
    Bergenstal RM; Kerr MSD; Roberts GJ; Souto D; Nabutovsky Y; Hirsch IB
    J Endocr Soc; 2021 Apr; 5(4):bvab013. PubMed ID: 33644623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing clinical outcomes between two continuous glucose monitors: similar diabetes-related events, all-cause hospitalizations and HbA1c reductions in type 1 and type 2 diabetes.
    Miller E; Roberts GJ; Joseph JM; Nabutovsky Y; Reyes IJ; Souto D; Virdi N; Hirsch IB
    Am J Med Open; 2023 Jun; 9():100008. PubMed ID: 39035057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initiating GLP-1 Therapy in Combination with FreeStyle Libre Provides Greater Benefit Compared with GLP-1 Therapy Alone.
    Wright EE; Roberts GJ; Chuang JS; Nabutovsky Y; Virdi N; Miller E
    Diabetes Technol Ther; 2024 May; ():. PubMed ID: 38669474
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: AWeSoMe study group real-life observational experience.
    Landau Z; Abiri S; Gruber N; Levy-Shraga Y; Brener A; Lebenthal Y; Barash G; Pinhas-Hamiel O; Rachmiel M
    Acta Diabetol; 2018 Dec; 55(12):1303-1310. PubMed ID: 30171412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming diabetes care with continuous glucose monitoring: Rationale for expanded eligibility criteria.
    Hirsch BR
    J Am Assoc Nurse Pract; 2024 Jul; 36(7):385-390. PubMed ID: 38669198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study.
    Kjölhede K; Berntorp K; Kristensen K; Katsarou A; Shaat N; Wiberg N; Knop FK; Kristensen L; Dotevall A; Elfvin A; Sandgren U; Sengpiel V; Englund-Ögge L
    Acta Obstet Gynecol Scand; 2021 May; 100(5):927-933. PubMed ID: 33176006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical Considerations for Initiating and Utilizing Flash Continuous Glucose Monitoring in Clinical Practice.
    Wysham CH; Kruger DF
    J Endocr Soc; 2021 Sep; 5(9):bvab064. PubMed ID: 34291180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes Telehealth Solutions: Improving Self-Management Through Remote Initiation of Continuous Glucose Monitoring.
    Gal RL; Cohen NJ; Kruger D; Beck RW; Bergenstal RM; Calhoun P; Cushman T; Haban A; Hood K; Johnson ML; McArthur T; Olson BA; Weinstock RS; Oser SM; Oser TK; Bugielski B; Strayer H; Aleppo G
    J Endocr Soc; 2020 Sep; 4(9):bvaa076. PubMed ID: 32864542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Efficacy of Technology in Type 1 Diabetes: A Systematic Review, Network Meta-analysis, and Narrative Synthesis.
    Pease A; Lo C; Earnest A; Kiriakova V; Liew D; Zoungas S
    Diabetes Technol Ther; 2020 May; 22(5):411-421. PubMed ID: 31904262
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of continuous glucose monitoring in subjects with type 1 diabetes on multiple daily injections versus continuous subcutaneous insulin infusion therapy: a prospective 6-month study.
    Garg SK; Voelmle MK; Beatson CR; Miller HA; Crew LB; Freson BJ; Hazenfield RM
    Diabetes Care; 2011 Mar; 34(3):574-9. PubMed ID: 21278138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Improvements in Glycemic Control with Dexcom CGM Use in Adults with Noninsulin-Treated Type 2 Diabetes.
    Layne JE; Jepson LH; Carite AM; Parkin CG; Bergenstal RM
    Diabetes Technol Ther; 2024 Jun; ():. PubMed ID: 38904213
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.